1. Introduction

Biotechnology Criminal Governance Accountability refers to the legal and institutional framework through which governments, regulators, biotechnology companies, laboratories, researchers, healthcare institutions and other responsible persons are held accountable for criminal offences, regulatory violations, misuse of biological materials, genetic engineering risks, and harm caused by biotechnology-related activities.

It combines three principal concepts:

Criminal governance: Establishing laws, prohibitions, enforcement agencies, investigation procedures and criminal penalties for unlawful biotechnology activities.

Accountability: Identifying the individuals or organizations legally responsible for misconduct, negligence, concealment, unauthorized experimentation or unlawful release of biological materials.

Governance oversight: Ensuring that biotechnology is developed and used consistently with public safety, human rights, environmental protection, scientific integrity and the rule of law.

In India, this is not a single, separately codified doctrine. It is a framework derived from several statutes, constitutional principles, regulatory rules and judicial decisions.

The subject is particularly important where biotechnology involves genetically modified organisms (GMOs), hazardous microorganisms, genetic testing, biological research, pharmaceutical manufacturing, gene therapies, biosafety incidents and the possible misuse of biological materials.

2. Objectives of criminal governance accountability

The principal objectives are:

Public protection: Preventing criminal conduct that threatens human health, animal health, agriculture or the environment.

Regulatory compliance: Ensuring that biotechnology activities comply with statutory approvals, licences, containment requirements and safety conditions.

Individual responsibility: Determining whether researchers, laboratory directors, corporate officers or other persons committed, authorized or knowingly permitted an offence.

Corporate accountability: Preventing companies from using their separate legal personality to evade liability for offences committed through their operations.

Transparency and reporting: Encouraging the timely reporting of accidents, unauthorized releases, falsified research records and regulatory breaches.

Effective remedies: Supporting lawful investigation, prosecution, compensation, remediation and prevention of repeated violations.

A fundamental distinction must be maintained: a biosafety failure is not automatically a criminal offence. Criminal liability depends on the applicable statutory provision, the elements of the offence and the required mental state, where relevant. Civil liability, regulatory sanctions and criminal prosecution may operate separately.

3. Legal framework in India

A. Environment (Protection) Act, 1986

Provides powers to regulate environmental hazards, prescribe standards and issue directions. Sections 15–17 contain offence and liability provisions, as amended, including provisions relevant to companies and government departments. The exact applicable penalty and procedure must be checked against the law in force on the date of the alleged offence.

B. Rules governing genetically engineered organisms, 1989

The Rules on the Manufacture, Use, Import, Export and Storage of Hazardous Micro-organisms/Genetically Engineered Organisms or Cells establish controls and approval requirements under the Environment (Protection) Act. Rule 7 is particularly relevant to prohibited or unauthorized activities involving specified organisms and cells.

C. Biological Diversity Act, 2002

Regulates aspects of access to biological resources, associated traditional knowledge and benefit-sharing. Its applicability depends on the activity and the statutory requirements. It should not be confused with a general criminal prohibition on all biotechnology research.

D. Drugs and Cosmetics Act, 1940, and applicable rules

Relevant to regulated biological products, medicines, vaccines and certain gene- or cell-based therapies. Manufacturing, testing, labelling, distribution or sale that violates applicable statutory requirements can attract regulatory or criminal consequences.

E. General criminal law

The Bharatiya Nyaya Sanhita, 2023 (in force from 1 July 2024), may apply to conduct such as causing death or injury, criminal negligence, cheating, forgery, falsification or other offences, where the statutory elements are established. Procedural matters are governed by the applicable criminal procedure law, including the Bharatiya Nagarik Suraksha Sanhita, 2023.

Other relevant frameworks may include the Food Safety and Standards Act, 2006; the Biological Diversity Act and its applicable amendments; the Information Technology Act, 2000, where relevant to unlawful data handling; and the rules governing biomedical and health research.

The applicable legal regime depends on whether the alleged conduct concerns a human subject, a biological product, an engineered organism, environmental release, genetic information or a different activity.

4. Leading case laws and their legal significance

The following Supreme Court decisions are particularly relevant to biotechnology governance and accountability. Some directly concern genetically modified organisms, while others establish broader environmental liability principles applicable to biotechnology-related harm.

Case 1: Gene Campaign v. Union of India (2024)

2024 INSC 545 · Supreme Court of India · Judgment dated 23 July 2024

Facts: The litigation concerned the regulatory framework for genetically engineered organisms and the approval process for genetically modified mustard, DMH-11. The petitioners challenged aspects of the regulatory safeguards and the government's environmental approval process.

Legal issues:

Whether decisions of biotechnology regulators are subject to judicial review.

Whether biosafety safeguards sufficiently protect health and the environment.

Whether scientific decision-making should be transparent and account for conflicts of interest.

Decision and significance: The Court agreed that regulatory decisions concerning GMOs are subject to judicial review. It directed the Union Government to formulate a national policy on GM crops through consultation with relevant stakeholders and addressed the verification and disclosure of experts' conflicts of interest. The two judges differed on whether the particular DMH-11 approval was lawful, so that issue was to be reconsidered by an appropriately constituted Bench.

Sci API+1

Relevance to criminal governance accountability: The case demonstrates that biotechnology regulators must be answerable for their decisions. Transparent records, defensible scientific assessments and effective oversight can help detect misconduct and prevent unlawful approvals.

However, the case did not establish that a defective GMO approval automatically constitutes a criminal offence. Criminal liability must be established separately under applicable law.

Case 2: Alembic Pharmaceuticals Ltd. v. Rohit Prajapati (2020)

2020 INSC 326 · Supreme Court of India · Judgment dated 1 April 2020

Facts: Industrial units had commenced or expanded operations without obtaining the environmental clearance required under the applicable environmental impact assessment framework.

Legal principle: The Supreme Court held that granting retrospective environmental clearance to regularize operations that had commenced unlawfully was contrary to the applicable framework and the precautionary principle. It nevertheless found that the NGT's closure and revocation directions did not satisfy proportionality in the circumstances and directed the units to pay additional compensation.

Indian Kanoon+1

Relevance to biotechnology: A biotechnology facility cannot assume that later regulatory approval will necessarily cure an earlier statutory violation. Depending on the facts, unauthorized activities may result in regulatory sanctions, compensation, closure, or criminal proceedings under the applicable legislation.

Accountability lesson: Prior approval, accurate disclosures and compliance monitoring must be treated as substantive legal obligations, not merely administrative formalities.

Case 3: Indian Council for Enviro-Legal Action v. Union of India (1996)

1996 (3) SCC 212 · Supreme Court of India

Facts: Chemical industries in Bichhri, Rajasthan, caused serious environmental contamination through the handling and disposal of hazardous industrial waste.

Legal principle: The Court applied the principle of absolute liability to hazardous or inherently dangerous industrial activities and required responsible industries to bear the costs of remedial measures. The decision also reinforced the polluter-pays principle.

Indian Kanoon+1

Relevance to biotechnology: If a biotechnology enterprise causes environmental harm through a hazardous activity, the responsible entity may be required to fund remediation and may face additional statutory or tort liability.

Important distinction: Absolute liability in environmental law is not identical to criminal guilt. A compensation order does not, by itself, establish that a particular person committed a criminal offence.

Case 4: Vellore Citizens' Welfare Forum v. Union of India (1996)

(1996) 5 SCC 647 · Supreme Court of India

Facts: The litigation concerned environmental damage associated with untreated effluents from tanneries in Tamil Nadu.

Legal principle: The Supreme Court recognized the precautionary principle and polluter-pays principle as important components of Indian environmental law, read in the context of sustainable development.

abs.nls.ac.in+1

Relevance to biotechnology: Where a proposed biological release, laboratory operation or biotechnology process presents a credible risk of serious environmental harm, regulators should consider preventive measures rather than wait for irreversible damage.

Accountability lesson: Governance should emphasize prevention, risk assessment, documentation and enforceable safety conditions.

Case 5: S. Jagannath v. Union of India (1997)

(1997) 2 SCC 87 · Supreme Court of India

Facts: The dispute concerned intensive shrimp aquaculture and its environmental effects on coastal ecosystems.

Legal principle: The Court addressed the need to regulate environmentally damaging commercial activities and protect coastal ecology.

abs.nls.ac.in

Relevance to biotechnology: The case provides broader support for regulating commercial activities that threaten biodiversity and ecosystems, including biological production systems where the applicable facts and legislation bring them within the same environmental principles.

It is not a direct criminal prosecution concerning genetic engineering; its significance is in environmental governance and preventive accountability.

5. Comparison of the leading decisions

These cases establish important foundations for biotechnology governance, but they do not create one universal criminal-liability rule. The relevant offence, evidence and statutory requirements must still be examined in each matter.

6. Who can be held accountable?

Biotechnology criminal governance requires responsibility to be assigned according to each person's role, conduct and legal duties.

Researchers and laboratory personnel

May face liability for intentional unlawful conduct, falsification, unauthorized handling or release of regulated organisms, or other offences where the statutory elements are satisfied.

Biotechnology companies

May face corporate prosecution, financial penalties, licence consequences, remediation obligations or other sanctions, subject to the applicable statute and procedural requirements.

Directors and responsible officers

Personal liability may arise where legislation provides for it and the relevant conditions are established—for example, responsibility for the company's business, consent to an offence, connivance or neglect, as applicable.

Regulators and public officials

May be subject to disciplinary, administrative, judicial or criminal accountability where legally established misconduct, corruption, abuse of authority or dereliction of duty meets the relevant legal requirements.

Corporate position alone does not prove an individual's criminal guilt. Prosecutors must establish the applicable statutory basis for personal liability.

7. Common categories of biotechnology-related offences

The following are illustrative categories. Whether conduct is criminal depends on the precise facts and governing legislation.

A further distinction concerns accidents. An accidental laboratory exposure may justify mandatory reporting, investigation and corrective measures without necessarily establishing criminal negligence. Deliberate concealment, falsification or disregard of a legally imposed duty may change the analysis.

8. Institutional governance and enforcement

Effective accountability requires more than imposing penalties after an incident.

In India, the institutional framework may include:

Genetic Engineering Appraisal Committee (GEAC): Plays a central role in specified approvals involving genetically engineered organisms under the applicable rules.

Institutional Biosafety Committees (IBSCs): Support institutional biosafety review and oversight in the relevant research and laboratory settings.

State Biotechnology Coordination Committees (SBCCs) and District Level Committees (DLCs): Perform functions assigned under the 1989 Rules, including specified monitoring and enforcement activities.

Environmental regulators: Exercise powers under the relevant environmental statutes.

Drug regulators: Oversee regulated pharmaceutical and biological products within their respective statutory jurisdictions.

Police, prosecutors and courts: Investigate and adjudicate criminal offences under the applicable procedural and substantive laws.

The exact powers of each body depend on the governing statute, applicable rules, delegation and the nature of the alleged violation.

9. A practical accountability model

A sound biotechnology governance system should follow a documented sequence:

1

Risk identification

Identify the biological activity, hazards and applicable legal duties.

2

Prior authorization

Verify approvals, licences, containment conditions and reporting obligations.

3

Monitoring and records

Maintain traceable research records, audit trails and incident reports.

4

Investigation

Preserve evidence, establish causation and determine who had which responsibilities.

5

Legal classification

Distinguish regulatory breaches, civil liability and potential criminal offences.

6

Enforcement and prevention

Apply proportionate lawful sanctions and implement corrective safeguards.

This model supports fair enforcement by connecting the risk, the applicable duty, the evidence and the legal consequence.

10. Constitutional foundations

Three constitutional principles are particularly relevant to Indian biotechnology governance.

Article 14 — Equality before the law

Regulatory decisions should be non-arbitrary and consistent with the law. Selective enforcement or arbitrary treatment of similarly situated entities may be challenged through judicial review.

Article 21 — Protection of life and personal liberty

The Supreme Court has interpreted Article 21 to encompass important dimensions of health and environmental protection. In biotechnology regulation, this supports the need for legally adequate safeguards against serious risks to human life and health.

Articles 32 and 226 — Constitutional remedies

The Supreme Court and High Courts can review unlawful government action and grant appropriate constitutional remedies. The Gene Campaign litigation illustrates judicial scrutiny of GMO regulatory decisions.

Indian Kanoon+1

These constitutional provisions do not automatically establish criminal liability. They principally inform the legality of government action, the protection of rights and the availability of judicial remedies.

11. International dimensions

Biotechnology governance may also involve international standards and obligations, including:

Convention on Biological Diversity (CBD): Addresses biodiversity conservation, sustainable use and benefit-sharing.

Cartagena Protocol on Biosafety: Establishes an international framework concerning the safe handling, transport and use of living modified organisms within its scope.

International health cooperation: May be relevant to infectious disease surveillance, laboratory safety and cross-border biological risks.

International obligations can influence domestic legislation and regulatory practice. However, an international instrument does not automatically create a directly enforceable domestic criminal offence in every circumstance; implementation and applicable domestic law must be examined.

12. Critical challenges

Several difficulties affect effective criminal governance accountability in biotechnology:

Scientific complexity: Establishing causation between a biological activity and resulting harm can require specialist evidence.

Attribution of responsibility: Multiple researchers, contractors, laboratories and corporate decision-makers may have contributed to an incident.

Regulatory fragmentation: Responsibilities may be divided among environmental, pharmaceutical, agricultural and public-health authorities.

Delayed detection: Biological or ecological effects may emerge long after the activity that caused them.

Corporate opacity: Inadequate records and unclear decision-making structures can obstruct investigations.

Balancing innovation and safety: Excessively weak oversight can expose the public to avoidable risks, while arbitrary enforcement can undermine legitimate scientific research.

Potential improvements include clearer reporting duties, independent biosafety audits, documented allocation of responsibilities, appropriate whistleblower protection, conflict-of-interest disclosure, reliable evidence preservation and consistent enforcement.

13. Hypothetical example

Suppose a biotechnology company conducts a regulated field trial involving a genetically engineered organism without obtaining a legally required approval.

Regulatory question: Was the approval required, and which provisions govern the trial?

Evidence question: What do the trial records, permits, correspondence and scientific evidence establish?

Individual responsibility: Who authorized or conducted the trial, and what duties did each person have?

Corporate responsibility: Does the applicable law permit prosecution or penalties against the company and, under specified conditions, responsible officers?

Remedial response: Are containment, environmental monitoring, restoration or other protective measures necessary?

Criminal determination: Has the prosecution established each element of a particular offence to the applicable standard of proof?

The absence of approval may establish a regulatory violation, but further facts and legal analysis are necessary to determine the precise criminal consequences. No individual should be treated as guilty merely because an incident occurred within their organization.

14. Conclusion

Biotechnology Criminal Governance Accountability is best understood as a framework for ensuring that biological research, genetic engineering, pharmaceutical development and related activities remain subject to lawful oversight and meaningful responsibility.

Indian law provides several complementary mechanisms: biosafety approvals, environmental regulation, pharmaceutical controls, corporate liability provisions, constitutional review and general criminal law. The case law—particularly Gene Campaign, Alembic Pharmaceuticals, Indian Council for Enviro-Legal Action and Vellore Citizens' Welfare Forum—helps explain how transparency, preventive regulation, legal compliance and responsibility for harm interact.

The central legal principle is that biotechnology innovation must operate within enforceable legal safeguards, while criminal punishment must rest on a clearly applicable offence and properly established evidence.

For a more focused legal study, the next useful step would be to examine Biotechnology Criminal Governance Accountability under Indian law section by section, including the applicable statutory provisions, leading judgments, corporate-officer liability and possible penalties.